~~<i id='D9CF23815C'><strike id='D9CF23815C'><tt id='D9CF23815C'><pre id='D9CF23815C'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

fashion

author：Wikipedia 2025-09-07 11:16:31 - browse：238

Roche’s announcement Monday that it would pay $310 million for rights to a hypertension treatment, zilebesiran, invented by the biotech firm Alnylam is evidence of a renewed interest on the part of large pharmaceutical companies for treatments for cardiovascular disease.

If things go well, Roche could pay Alnylam up to $2.8 billion in total.

Heart drugs were once the most lucrative category of pharmaceuticals, but they have been eclipsed by treatments for cancer and other diseases as drug firms have struggled to one-up existing treatments for high blood pressure and high cholesterol that are now available as cheap generics.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： Radiology is caught between AI's potential and concern for patients

explore

Wikipedia

hotspot

focus

explore

hotspot

AdobeFederalhealthtechnologyregulatorsonWednesdayfinalizednewrulestoforcesoftwarevendorstodiscloseho

WSS

A Q&A with Gavi’s Seth Berkley on vaccines, Covid, and more

Tocagen's brain cancer gene therapy trial continues. Investors worry

Wife of Gilgo Beach murder suspect files for divorce, court filing shows

Judge rejects Trump's request to move Stormy Daniels hush

CMS should re

Winning ticket for $1 billion Powerball jackpot sold in California

hotspot

fashion

explore

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Roche to buy Carmot Therapeutics, developer of obesity drugs

Walensky prepares to leave CDC — and Congress — behind

Radiology is caught between AI's potential and concern for patients

Wildfire smoke exposes gaps in outdoor worker protections

FDA needs staff influx to meet gene therapy needs, Marks says

Virginia high school admissions case could be legal follow

Roche to buy Carmot Therapeutics, developer of obesity drugs

At least 13 dead in Texas as scorching temps continue

SCOTUS to consider access to abortion pill mifepristone

Wikipedia

Pregnancy discrimination could be enabled by AI

A Q&A with Gavi’s Seth Berkley on vaccines, Covid, and more

A Q&A with Gavi’s Seth Berkley on vaccines, Covid, and more

In diabetes hearing, Sanders takes on a new foe: food makers

FDA approves world's first CRISPR

The woman behind the Dana Farber

hotspot

focus

explore

hotspot